Skip to main content
OpenTrials

Clinical trial condition

Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable

Explore clinical trials studying Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable trial results

Completed

Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer

NCT01108055

Conditions
Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable, Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy), +17 more
Locations
  • Stanford University School of Medicine Stanford, California, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details

Related conditions